Showing results (661-670 of 1,671) with videos related to
Sort By:
Pageof 168
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|November 7, 1999
[Management of submacular hemorrhage by tissue plasminogen activator and SF(6) gas injection]P Meier, C Zeumer, C Jochmann, et al.European Journal of Clinical Microbiology|June 1, 1984
Pasteurella multocida septicemia not associated with primary liver diseaseM Grehn, F Müller, A Hany, et al.Revue Medicale Suisse|July 25, 2009
[Goodpasture syndrome associated with p-ANCA microscopic vasculitis: a rare entity to recognize]G Pralong, C Fournier, E Dayer, et al.Die Rehabilitation|May 1, 1991
[The significance of intra-clinical outcome criteria in geriatric rehabilitation--results of an after-care project on the issue of quality assurance]S Görres, H Tschubar, H P Meier-BaumgartnerTherapeutische Umschau. Revue Therapeutique|June 1, 1997
[Goals in rehabilitation: assessment and outcome evaluation]H P Meier-Baumgartner, W von Renteln-KruseZeitschrift Fur Orthopadie Und Ihre Grenzgebiete|November 1, 1989
[Chronic pain syndromes in orthopedics--typical sites, follow-up and patient characteristics]A Molsberger, K U Jensen, U Müller, et al.Molecular Psychiatry|February 28, 2007
Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controlsJ H Barnett, P B Jones, T W Robbins, et al.Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 8, 2007
Interobserver agreement in two- and three-dimensional power Doppler sonographic assessment of synovial vascularity during anti-inflammatory treatment in patients with rheumatoid arthritisJ Strunk, K Strube, C Rumbaur, et al.Deutsche Medizinische Wochenschrift (1946)|September 17, 2004
[Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous?]H Schwertz, U Müller-Werdan, R Prondzinsky, et al.Rheumatology (Oxford, England)|October 14, 2004
Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot studyT Bongartz, B Coras, T Vogt, et al.Pageof 168